Philipp Lurz, Thomas Schmitz, Tobias Geisler, Jörg Hausleiter, Ingo Eitel, Volker Rudolph, Edith Lubos, Ralph Stephan von Bardeleben, Nedy Brambilla, Federico De Marco, Sergio Berti, Holger Nef, Axel Linke, Christian Hengstenberg, Stephan Baldus, Konstantinos Spargias, Paolo Denti, Georg Nickenig, Helge Möllmann, Wolfgang Rottbauer, Fabien Praz, Christian Butter, Markus Reinthaler, Nicolas M Van Mieghem, Mohammad Sherif, Martin Swaans, Adam Witkowski, Mamta Buch, Tim Seidler, Andrés Iñiguez, Holger Thiele, Mareike Eißmann, Juergen Schreieck, Michael Näbauer, Leo Marcoff, Konstantinos Koulogiannis, Tienush Rassaf, Peter Luedike
BACKGROUND: Mitral transcatheter edge-to-edge repair (M-TEER) is a guideline-recommended treatment option for patients with severe symptomatic mitral regurgitation (MR). Outcomes with the PASCAL system in a post-market setting have not been established. OBJECTIVES: The authors report 30-day and 1-year outcomes from the MiCLASP (Transcatheter Repair of Mitral Regurgitation with Edwards PASCAL Transcatheter Valve Repair System) European post-market clinical follow-up study...
April 8, 2024: JACC. Cardiovascular Interventions